• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

“在停止使用任何药物之前,你都不算戒毒成功”:阿巴拉契亚农村地区对药物辅助治疗的认知

"You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.

作者信息

Richard Emma L, Schalkoff Christine A, Piscalko Hannah M, Brook Daniel L, Sibley Adams L, Lancaster Kathryn E, Miller William C, Go Vivian F

机构信息

Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.

Department of Health Behavior, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Int J Drug Policy. 2020 Nov;85:102704. doi: 10.1016/j.drugpo.2020.102704. Epub 2020 Mar 12.

DOI:10.1016/j.drugpo.2020.102704
PMID:32173274
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8018539/
Abstract

BACKGROUND

Medication-assisted treatment (MAT) is an evidence-based strategy to treat opioid use disorder (OUD). However, MAT-related stigma reduces MAT uptake, which is particularly low in rural areas. To date, perceptions and attitudes towards MAT in rural settings have not been described.

OBJECTIVE

This qualitative study aims to characterize perceptions and attitudes towards MAT and the environmental factors contributing to these views in Appalachian Ohio.

METHODS

From February to July 2018, semi-structured interviews were conducted with 34 stakeholders (12 healthcare professionals, 12 substance use treatment providers, 7 law enforcement agents and judicial officials, and 3 members of relevant organizations) in three rural counties in Appalachian Ohio. Interviews were transcribed, coded, and analyzed to characterize the risk environment and participants' perceptions and attitudes towards MAT.

RESULTS

Participants expressed or described pervasive MAT-related stigma in the region. Participants consistently described three elements of the environment affecting stigma: (1) a "conservative" culture in which abstinence is necessary to be in recovery successfully, (2) fear of medication diversion and abuse, and (3) drug court policies that keep MAT out of the criminal justice system.

CONCLUSION

MAT-related stigma will need to be addressed to tackle the opioid epidemic through evidence-based treatment effectively.

摘要

背景

药物辅助治疗(MAT)是一种基于证据的治疗阿片类物质使用障碍(OUD)的策略。然而,与MAT相关的污名化降低了MAT的采用率,在农村地区尤其低。迄今为止,农村地区对MAT的看法和态度尚未得到描述。

目的

这项定性研究旨在描述俄亥俄州阿巴拉契亚地区对MAT的看法和态度以及促成这些观点的环境因素。

方法

2018年2月至7月,对俄亥俄州阿巴拉契亚地区三个农村县的34名利益相关者(12名医疗保健专业人员、12名物质使用治疗提供者、7名执法人员和司法官员以及3名相关组织成员)进行了半结构化访谈。对访谈内容进行转录、编码和分析,以描述风险环境以及参与者对MAT的看法和态度。

结果

参与者表达或描述了该地区普遍存在的与MAT相关的污名化。参与者一致描述了影响污名化的环境的三个要素:(1)一种“保守”文化,即成功康复必须禁欲;(2)对药物转移和滥用的恐惧;(3)使MAT被排除在刑事司法系统之外的毒品法庭政策。

结论

需要解决与MAT相关的污名化问题,以便通过循证治疗有效应对阿片类药物流行。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822e/8018539/75826bf87e81/nihms-1575984-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822e/8018539/75826bf87e81/nihms-1575984-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/822e/8018539/75826bf87e81/nihms-1575984-f0001.jpg

相似文献

1
"You are not clean until you're not on anything": Perceptions of medication-assisted treatment in rural Appalachia.“在停止使用任何药物之前,你都不算戒毒成功”:阿巴拉契亚农村地区对药物辅助治疗的认知
Int J Drug Policy. 2020 Nov;85:102704. doi: 10.1016/j.drugpo.2020.102704. Epub 2020 Mar 12.
2
"Now We Are Seeing the Tides Wash In": Trauma and the Opioid Epidemic in Rural Appalachian Ohio.“如今,我们看到潮水涌来”:俄亥俄州阿巴拉契亚农村地区的创伤与阿片类药物泛滥。
Subst Use Misuse. 2021;56(5):650-659. doi: 10.1080/10826084.2021.1887248. Epub 2021 Mar 7.
3
Online Medication Assisted Treatment Education for Court Professionals: Need, Opportunities and Challenges.在线药物辅助治疗法庭专业人员教育:需求、机遇与挑战。
Subst Use Misuse. 2021;56(10):1439-1447. doi: 10.1080/10826084.2021.1936045. Epub 2021 Jun 21.
4
Court personnel attitudes towards medication-assisted treatment: A state-wide survey.法庭工作人员对药物辅助治疗的态度:全州范围的调查。
J Subst Abuse Treat. 2019 Sep;104:72-82. doi: 10.1016/j.jsat.2019.06.011. Epub 2019 Jun 28.
5
The Role of Primary Care in Improving Access to Medication-Assisted Treatment for Rural Medicaid Enrollees with Opioid Use Disorder.初级保健在改善农村医疗补助计划参保者阿片类药物使用障碍患者获得药物辅助治疗方面的作用。
J Gen Intern Med. 2019 Jun;34(6):936-943. doi: 10.1007/s11606-019-04943-6. Epub 2019 Mar 18.
6
Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers.宾夕法尼亚州农村获取 MAT(RAMP):一项混合实施研究方案,旨在促进农村初级保健提供者采用药物辅助治疗。
Addict Sci Clin Pract. 2019 Aug 1;14(1):25. doi: 10.1186/s13722-019-0154-4.
7
Does a Rural Community-Based Intervention Improve Knowledge and Attitudes of Opioid Use Disorder and Medication-Assisted Treatment? A Report From the IT MATTTRs Study.农村社区为基础的干预是否能改善阿片类药物使用障碍和药物辅助治疗的知识和态度?来自 IT MATTTRs 研究的报告。
J Rural Health. 2022 Jan;38(1):120-128. doi: 10.1111/jrh.12545. Epub 2020 Nov 26.
8
Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.农村和阿巴拉契亚地区新生儿戒断综合征发病率及阿片类药物滥用治疗可及性的差异。
J Rural Health. 2018 Dec;34(1):6-13. doi: 10.1111/jrh.12251. Epub 2017 Jul 7.
9
Improving Access to Treatment for Opioid Use Disorder in High-Need Areas: The Role of HRSA Health Centers.改善高需求地区阿片类物质使用障碍的治疗可及性:卫生资源与服务管理局健康中心的作用。
J Appalach Health. 2020 Sep 1;2(4):17-25. doi: 10.13023/jah.0204.04. eCollection 2020.
10
Medication-Assisted Treatment for Opioid Use Disorder in a Rural Family Medicine Practice.农村家庭医疗实践中的阿片类药物使用障碍药物辅助治疗。
J Prim Care Community Health. 2020 Jan-Dec;11:2150132720931720. doi: 10.1177/2150132720931720.

引用本文的文献

1
Examining geographic disparities in access to no-cost naloxone in North Carolina: A cross-sectional survey of naloxone distribution programs.考察北卡罗来纳州免费纳洛酮获取方面的地理差异:一项纳洛酮分发项目的横断面调查。
J Rural Health. 2025 Jun;41(3):e70069. doi: 10.1111/jrh.70069.
2
Methadone-involved overdose deaths in urban and rural communities before and after the public health emergency flexibilities for methadone take-home doses.在美沙酮带回家剂量的公共卫生应急灵活性措施实施前后,城市和农村社区中与美沙酮相关的过量死亡情况。
Drug Alcohol Depend Rep. 2025 Apr 24;15:100339. doi: 10.1016/j.dadr.2025.100339. eCollection 2025 Jun.
3

本文引用的文献

1
Understanding the use of diverted buprenorphine.理解丁丙诺啡的转用。
Drug Alcohol Depend. 2018 Dec 1;193:117-123. doi: 10.1016/j.drugalcdep.2018.09.007. Epub 2018 Oct 12.
2
Perceptions and practices addressing diversion among US buprenorphine prescribers.美国丁丙诺啡处方医生在处理药物滥用方面的认知和做法。
Drug Alcohol Depend. 2018 May 1;186:147-153. doi: 10.1016/j.drugalcdep.2018.01.015. Epub 2018 Mar 10.
3
A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices.
The importance of contextually specific support relationships in implementing programs to link people to medication for opioid use disorder (MOUD) treatment during reentry from county jails.
在从县监狱重新进入社会期间实施将人们与阿片类药物使用障碍(MOUD)治疗药物联系起来的项目时,因地制宜的支持关系的重要性。
Health Justice. 2025 Mar 31;13(1):20. doi: 10.1186/s40352-025-00330-y.
4
Mechanisms of resilience and coping to intersectional HIV prevention and drug-use stigma among people who inject drugs in rural Appalachian Ohio.俄亥俄州阿巴拉契亚农村地区注射毒品者应对交叉性艾滋病毒预防和吸毒污名的复原力机制
Harm Reduct J. 2025 Feb 19;22(1):18. doi: 10.1186/s12954-025-01160-9.
5
Understanding MAT access in the context of unused MAT capacity in the United States: when increasing rural MAT capacity is not enough.在美国未使用的药物辅助治疗(MAT)能力背景下理解MAT的可及性:增加农村地区MAT能力为何不足。
Subst Abuse Treat Prev Policy. 2024 Dec 20;19(1):47. doi: 10.1186/s13011-024-00628-4.
6
Perceptions of substance use disorder in rural areas: how the brain disease model impacts public stigma.农村地区对物质使用障碍的认知:脑部疾病模型如何影响公众污名化。
BMC Public Health. 2024 Dec 18;24(1):3531. doi: 10.1186/s12889-024-20682-8.
7
The Implementation Climate for Integrating Buprenorphine Prescribing into Rural Primary Care.将丁丙诺啡处方纳入农村初级保健的实施环境
J Gen Intern Med. 2024 Dec 12. doi: 10.1007/s11606-024-09260-1.
8
Differences in Religious Commitment and Harm Reduction Attitudes Among US Medical Students by Sex Assigned at Birth: A Pilot Study.按出生时指定性别划分的美国医学生在宗教信仰和减少伤害态度上的差异:一项试点研究。
J Relig Health. 2024 Oct 29. doi: 10.1007/s10943-024-02155-9.
9
Limited acceptance of buprenorphine in recovery residences in South Florida: A secret shopper survey.南佛罗里达州康复住所中丁丙诺啡的接受度有限:一项秘密购物者调查。
J Subst Use Addict Treat. 2025 Jan;168:209535. doi: 10.1016/j.josat.2024.209535. Epub 2024 Oct 5.
10
Expanding the opioid use disorder medication treatment workforce in rural communities through the RCORP initiative.通过农村社区药剂师计划倡议扩大农村社区阿片类药物使用障碍药物治疗工作队伍。
J Rural Health. 2025 Jan;41(1):e12867. doi: 10.1111/jrh.12867. Epub 2024 Jul 25.
一项比较美国基层医疗实践中医生报告的使用丁丙诺啡和纳曲酮治疗成瘾的障碍的定性研究。
Int J Drug Policy. 2018 Apr;54:9-17. doi: 10.1016/j.drugpo.2017.11.021. Epub 2018 Jan 8.
4
Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder.农村医生在开具丁丙诺啡治疗阿片类药物使用障碍方面面临的障碍。
Ann Fam Med. 2017 Jul;15(4):359-362. doi: 10.1370/afm.2099.
5
Access to and Payment for Office-Based Buprenorphine Treatment in Ohio.俄亥俄州基于办公室的丁丙诺啡治疗的获取与支付
Subst Abuse. 2017 Jun 13;11:1178221817699247. doi: 10.1177/1178221817699247. eCollection 2017.
6
Why aren't physicians prescribing more buprenorphine?为什么医生没有开出更多的丁丙诺啡?
J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12.
7
Structural stigma: Research evidence and implications for psychological science.结构性污名:研究证据及其对心理科学的影响
Am Psychol. 2016 Nov;71(8):742-751. doi: 10.1037/amp0000068.
8
Treatment utilization among persons with opioid use disorder in the United States.美国阿片类药物使用障碍患者的治疗利用情况。
Drug Alcohol Depend. 2016 Dec 1;169:117-127. doi: 10.1016/j.drugalcdep.2016.10.015. Epub 2016 Oct 19.
9
American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use.美国成瘾医学协会(ASAM)关于使用药物治疗阿片类药物使用成瘾的国家实践指南。
J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166.
10
Stigma from the Viewpoint of the Patient.患者视角下的污名化
J Addict Dis. 2015;34(2-3):238-47. doi: 10.1080/10550887.2015.1059714.